Navigation auf


Life Science Zurich Communication & Events

Redundancies in T cells

Cancer immunotherapy enables T cells (front) to attack and eliminate tumour cells (dark red). (Visualisations: Shutterstock)

Researchers at ETH Zurich have discovered redundancies in the biochemical signalling pathways of immune cells. This finding has important implications for advances in cancer immunotherapy, among other areas.